Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SilkLife hydrogel-encapsulated platelet-rich plasma versus pure platelet-rich plasma for knee osteoarthritis
TCTR20260917001Phase 0Not yet recruiting
- Sponsor
- Thun Itthipanichpong
- Start
- Sep 2026
- Countries
- 1
01
Overview
Phase 0, open-label trial of platelet-rich plasma in knee osteoarthritis (OA) (2 arms), sponsored by Thun Itthipanichpong. Primary endpoints: Visual Analog Scale at 26 weeks, WOMAC score at 26 weeks and 3 more. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on TCTR20260917001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260917001.